Skip to main content


European Journal of Nuclear Medicine and Molecular Imaging

European Journal of Nuclear Medicine and Molecular Imaging OnlineFirst articles

21.11.2017 | Original Article

Comparison of 18F–FDG PET/MRI and MRI alone for whole-body staging and potential impact on therapeutic management of women with suspected recurrent pelvic cancer: a follow-up study

Female pelvic cancer is a heterogeneous group of neoplasms including ovarian, cervical, endometrial, vaginal, and vulvar cancer. A common feature of female pelvic cancers is their considerable risk of recurrence after complete remission [ 1 – 3 ].

21.11.2017 | Original Article

Low baseline and subsequent higher aortic abdominal aneurysm FDG uptake are associated with poor sac shrinkage post endovascular repair

A growing number of patients with an abdominal aortic aneurysm (AAA) are treated by endovascular aneurysm repair (EVAR) in order to exclude the AAA sac from blood flow and pressure [ 1 , 2 ]. EVAR was recently shown to confer an early survival …

21.11.2017 | Original Article Open Access

Value of 18F–FDG PET/CT for predicting EGFR mutations and positive ALK expression in patients with non-small cell lung cancer: a retrospective analysis of 849 Chinese patients

Over the last decade, the introduction of tyrosine-kinase inhibitors (TKIs) has enabled a remarkable paradigm shift in the treatment of non-small cell lung cancer (NSCLC), especially in advanced adenocarcinoma (ADC). Epidermal growth factor …

21.11.2017 | Letter to the Editor

177Lu-PSMA-617 radioligand therapy in mCRPC: ready for phase III trial?

21.11.2017 | Original Article Open Access

Changes in multimodality functional imaging parameters early during chemoradiation predict treatment response in patients with locally advanced head and neck cancer

Radical chemoradiation (CRT) is widely accepted as the standard of care for organ-sparing treatment of locally advanced head and neck squamous cell carcinoma (HNSCC). However, it is now evident that locally advanced HNSCC represents a disease …

Aktuelle Ausgaben

Über diese Zeitschrift

Highly ranked among journals in its field, the European Journal of Nuclear Medicine and Molecular Imaging provides a forum for the exchange of clinical and scientific information for the nuclear medicine community and allied professions involved in the functional, metabolic and molecular investigation of disease. The journal remains of primary interest to practitioners in the field of nuclear medicine but also reports on original work relating to physics, dosimetry, radiation biology, radiochemistry and pharmacy. Original material examines the field of molecular imaging probes, reporter gene assays, cell trafficking, targeting of endogenous gene expression and antisense methodologies.
The Journal publishes in-depth reviews of topical interest, short communications, controversies, interesting images and letters to the Editor.

This is the official journal of the European Association of Nuclear Medicine (EANM). EANM members, and also members of the Japanese, Korean and Italian nuclear medicine societies have free access to EJNMMI. As part of this reciprocal agreement, EANM members also have free access to “Annals of Nuclear Medicine”, “Nuclear Medicine and Molecular Imaging” and to “Clinical and Translational Imaging”.

Weitere Informationen